Weifang Shengtai Pharmaceutical Co.,LTD., which is nbsp;a Wholly Foreign-Owned Enterprise  that controlled by U.S. Shengtai Holding Inc., has a registered capital of $3,920,000 and total asset of $33,760,000. Its principal office, which occupies an area of 233,000 square meters with over 800 staffs, is located in Hi-Tech Industrial Park of Changle County, Shandong Province, China.

Weifang Shengtai Pharmaceutical Co.,LTD. is engaged in the development, production and distribution of pharmaceutical raw materials (glucose, anhydrous glucose, sorbitol, mannitol ) and pharmaceutical preparations (starch, dextrin, polypropylene resin II, polypropylene resin III, polypropylene resin IV). With starch series, glucose series and Hi-Tech medicine materials as the core product, the company mainly produces "Hengdebao" brand corn processed series products and water soluble medicine coating materials. The company's product has rich variety and high quality, and received approval of national GMP certificates and ISO9000 Quality System certificates.our production pass HACCP/KOSHER/HALAL certificates too.

The products of the company have been exported to over 70 countries and areas. Glucose for pharmaceutical proposes, which is the company's core product, occupies over 30% market share in China, and the sales volume of glucose for injunction ranks No.1 domestically.

Though its well-known brand, market advantages, easy access to raw material and excellent & efficient quality system management, Weifang Shengtai Pharmaceutical Co.,LTD. will insists on substantial development strategy and developing new products with high extra-value to expand market share with the attempt of being the largest production base of glucose for medical proposes in China and a famous international glucose production base in three to five years.